chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Ct was to receive 0.1cc PPD for TB skin test on 08/16/04 - instead Ct. received Adult Td 05.cc ID. Ct. was not visually assessed by this nurse but reported left arm red/swollen.
After the injection i had a lump for at least a week as well as redness.  After about 1.5 weeks the lump went away.  But now on day 13 I have developed the red ring, well beyond the normal timeframe.  It is about 3 inches in diameter.
Broke out in rash on 9/24/03. Erythema rash (mac); diffuse. Positive vesicles throat. Suspect varicella despite vaccine.
This spontaneous report as received from a doctor of pharmacy refers to a female patient of unknown age. On 10-OCT-2012, the patient was vaccinated with a dose of ZOSTAVAX, subcutaneously (dose, lot number not reported). No other co-suspects were reported. No concomitant medications were reported. On 11-OCT-2012, the patient developed a swollen, hot, hard lump at the injection site, after receiving ZOSTAVAX, 2 days after onset of therapy. No treatment information was reported. The outcome of a swollen, hot, hard lump at the injection site was reported as not recovered/not resolved. The patient sought unspecified medical attention. The relatedness for a swollen, hot, hard lump at the injection site was not reported for ZOSTAVAX. Additional information has been requested.
Initial information received on 30 July 2010 from a consumer, who is the parent of the patient. A 13 year old female with no past medical history, no known allergies, was not on any concurrent medications and had no reported illness at time of vaccination, had received a "subcutaneous" left deltoid injection of ADACEL (lot number and needle length were unknown) on 27 July 2010 and a right deltoid injection of VARIVAX vaccination (lot number not known) in July of 2010. The patient then developed a "two inch red area with hematoma and a hard lump" at the site. The reporter plans to notify their physician on 30 July 2010. No further information was provided at the time of the report. Follow-up information was received 26 August 2010 from a consumer, who is the patient's parent. According to the reporter, the redness and hematoma completely resolved in approximately four to five days after vaccine administration. An outcome was not reported for the hard lump at the injection site. Documents held by sender: none.
PATIENT NOTICED IMPROPER TECHNIQUE WHEN GIVING VACCINE, SAID NEEDLE HIT TABLE BEFORE GIVING INTO HER ARM. A DAY OR TWO LATER SHE NOTICED REDNESS AROUND INJECTION, MARKED IT WITH A MARKER TO TRACK. CAME IN TO CLINIC TODAY TO GET TREATED FOR CELLULITIS, OBSERVED REDNESS EXPANDED INTO UPPER ARM, WARM TO TOUCH. PATIENT STATED SHE FELT TIRED AND SORE. NO FEVER REPORTED
I am not sure the details of the flu vaccine.  the employee health office would have that information.  About 10 minutes after my COVID vaccine I got really itchy with a notable rash on my arms.  NO hives at this time.  They wanted me to take benadryl and I stated that I did not like benadryl and had to drive (I should have).  They took my vital signs and my BP was extremely high for me (147, 157, 162/90s)  The laid me in a recliner to rest.  My tongue began to get itchy and felt thick and my lips felt numb and swollen.  They called the parametics and was taken to the ED.  I was with in walking idstance of ED but protocol was to go by ambo.  Once in the ED my lips and tongue continued to fell thick and swollen, I began to cough and had chest tighness.  I was given 25 mg IV benadryl and EKG was taken.  I got DC about 2-3 hour later prescriibed benadryl.  I took Benadryl till saturday evening with pepcid.  Sunday and Monday I took pepcid with zertec.  I still feel itchy and chest tighness.
Fever (beads of sweat on brow) and chills. Extreme paleness (white face noticed by work colleagues). Entire left arm (shoulder to fingertips) weak and sore 02/28/2010 through 03/02/2010.
This is a 71 year old male with PMH/PSH below presents to the ED for evaluation of altered mental status. Pt appears lethergic. All information obtained from the medical records and nursing. As per the record, EMS was called after missing a dialysis appointment. Patient has a left arm fistula for dialysis access. In the ED patient was afebrile. T-max 101. Vitals stable. Initial chemistry was hemolyzed. Repeat chemistry shows potassium of 6.0., creatinine 7.2. Patient has scheduled home dialysis on Tu, Thurs, Sat. As per Home Dialysis nurse, patient had missed his last dialysis treatment since Friday. In the ED, patient was pan-cultured and was started on Levaquin empirically. Chest x-ray shows Bilateral infiltrates with no effusions. Patient is currently getting hemodialysis.
Persistent sense of nausea; acute sensitivity to sweet smells: laundry detergent, cleaners, fragrances, body lotions on those around me.  Makes me feel very nauseous, headache
I developed thyroiditis a month after receiving the vaccine.  Symptoms included tachhycardia, jitters, tremors, anxiety and irratability
Pt. may have been given an expired vaccine. Sibling also vaccinated at the same time. Unable to know who got what vaccine
No immediate reaction. 2 days after injection client noted red, swollen area at injection site. Client sates this has never happened before. Client states she will send pic of it to telehealth provider for her employer if it does not resolve today.
Approximately 3:00 PM on the date of immunization, pt called SHC to report he was experiencing a local reaction at immunization site. Patient stated area is painful, red and warm with a raised patch approximately 2" inch diameter. "Advised cold compresses, anti-inflammatories if not counter indicated and to consult his PCP. Patient contacted this office about 1 week later stating problem was better but not resolved. On 3/12/08 patient reported problem continues, had X-Ray of left shoulder on this day.
Patient was tested for COVID 19 for preprocedural colonoscopy. Patient was positive and initially had no symptoms. Patient became symptomatic and presented to the hospital where he was hospitalized. Patient passed away from complications on 10/24/2021.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A 68-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Feb2021 as dose 1, single (Batch/Lot number: unknown), on 25Feb2021 as dose 2, single (Batch/Lot number: unknown), on 21Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) and on 23May2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 68 years for covid-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing), notes: HTN; "GERD" (unspecified if ongoing), notes: GERD; "HRT" (unspecified if ongoing), notes: HRT; "known allergies: Sulfa" (unspecified if ongoing), notes: known allergies: Sulfa. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jun2022) Negative; (Jun2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: The patient received other medication in 2 weeks of vaccination. Anti viral details: Paxlovid for treatment of COVID-19, from 13Jun2022 to 17Jun2022; Administrator route=Oral. 7 days after completion of Paxlovid renal dose she was again symptomatic and again tested positive on a rapid antigen COVID test, previously in the week had tested negative using the same home.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The reported Covid 19 positive after both the doses of  COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported events and BNT162B2 administration.
Client reported to ER on 1/11/03 with complaint of dizziness, mostly when standing; tachycardia of approx. 120. Other vital signs were normal per (ER report). He was given 25mg Atenolol and asked to take Atenolol 12.5mg daily and return to MD for follow-up. The follow up states, "reported to the ER on 1/11/03 with symptoms. The exact date and time of onset of symptoms is unclear from the ER report."
Information has been received from a physician concerning a 6 year old male with no known history or allergies who was vaccinated SC with a first and second 0.5 ml dose of mumps virus vaccine live on 15-NOV-2000 and 27-APR-2003, respectively.  There was no concomitant medication.  On 15-MAY-2006 the patient presented with a large parotiditis.  No other symptoms were noted and no treatment was needed.  It was reported that the patient had a positive Mumps IgG.  Symptoms resolved within 4-5 days.  There was no product quality complaint involved.  Additional information has been requested.
The patient was due for a dose of MMR and I administered Meningococcal instead. There were no adverse reactions. The provider on duty checked to make sure that the vaccine would not harm the patient. According to her contacts, the patient should not have any adverse reactions or long term issues. Then we reached out to the parent to give him this information and reschedule for the correct vaccine to be given.
pt recv vax 9JUN97 & 12JUN97 pt devel a mild case of chickenpox that consisted of less than 50 lesions mostly on feet & a green runny nose;reported that JUN97 pt mom noticed sign @ pt daycare had been exposed to chickenpox; This is in follow-up to report (s) previously submitted on 10/16/1997; 1/16/1998. Information has been received form a health care professional concerning a 17-month-old female patient who on 09JUN97 was vaccinated with one dose of VARIVAX SC. On 12JUN97 the patient developed a "mild case of chickenpox that consisted of less than 50 lesions mostly on her feet and a green runny nose." It was reported that in June of 1997 the patients' mother noticed a sign at the patient's daycare that stated that the 3-year-old class had been exposed to chickenpox. The mother was unsure whether her daugther's lesions were due to the vaccine or pre-exposure. No further details were provided. This is an amended report. The patient's age in the narrative now reads 17 month-old, instead of 16 month-old. This report is corrected as amended.
Within 8 hours of vaccine administration, patient had fever up to 103, cough, and ataxia. He called his PCP and he used Benadry and fever reducer.No further treatment needed. He was afebrile by next morning. Wife reported the reaction on 10/24/08 to the clinic. Unable to reach patient until 10/25/08 for confirmation of this.
Patient presented for vaccination today. During registration I recognized the patient from a previous vaccination clinic date. Patient was questioned if he was previously vaccinated and he responded that he was unsure. Patient presented with disorganized thinking and inappropriate flirtatious behavior. Provider contacted website at 10:00 AM to further research patient's history of prior vaccination. It was confirmed that he received the vaccination on 05/06/2021. After entering his information to re-print his label for his record, it was discovered that patient had 3 prior dates of vaccination in the system: 03/14/2021, 04/04/2021, and 05/06/2021. Patient was educated that he does not need any additional COVID vaccines and he is fully vaccinated. He was given another card with the 03/14/2021 date. Patient denied any complaints and was not in any distress.  Patient resides at the Salvation Army and his health and mental history is unknown.  Provider will notify staff of the Salvation Army of the events surrounding this patient to prevent further safety concerns. management was also notified of events.
Approx 2 hrs after receiving flu vaccine - inside of mouth burning and stinging.  Throat hurting and feeling like something in it.  Face reddened.  Eyes turned bloodshot and discharging mucus from them.  Wheezing and vomiting.  Later, body very achy.  Went to urgent care facility - gave me antihistamine, but didn't seem to know much.  The same thing happened to me last year when I received the flu vaccine.
achiness; minor chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (minor chills) and MYALGIA (achiness) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included Arthritis. Concomitant products included IBUPROFEN for Arthritis, SALBUTAMOL (ALBUTEROL HFA), FORMOTEROL FUMARATE, MOMETASONE FUROATE (DULERA), FOLIC ACID, TIOTROPIUM BROMIDE (SPIRIVA RESPIMAT), HYDROCHLOROTHIAZIDE, AMLODIPINE, VITAMIN D3, CALCIUM, MAGNESIUM OXIDE, ATORVASTATIN, ASCORBIC ACID (VITAMIN C ACID), ZINC and MULTIVITAMIN FOR WOMEN for an unknown indication.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced CHILLS (minor chills). On an unknown date, the patient experienced MYALGIA (achiness). At the time of the report, CHILLS (minor chills) and MYALGIA (achiness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       the Treatment information was not provided.
Currently admitted at (14 ) days inpatient. Acute hypoxic respiratory failure  Due to Covid-19 pneumonia  Pt received both vaccines and booster dose but suspect inadequate response due to immune suppression from renal transplant medications.  Symptoms began on 11/16  PCR + on 11/19/21 Hospitalized on 11/28/21 Cont with decadron daily CAP treatment given immune supression Exertional hypoxia.    Mild Aki on CKD 3  Hx of ESRD s.p Renal Transplant  On Cellcept and Prograf  Nephrology consult assistance for dosing above - espeically in light of creat bump from 1.2 to 1.5  Will repeat Cr in a.m. Suspect aki is pre renal from hypoxia and poor po intake in setting of covid   Essential HTN:  Cont norvasc and hold lisinopril for creat bump (based on meds from 2 weeks ago). Today's med history is pending.   Dyslipidemia: Cont crestor   Hypothyroidism: Cont synthroid    Vte prophy: high risk covid. Lovenox daily.    Diet: general with 2 Gm sodium 2 L fluid restriction    Code: full   HISTORY OF PRESENT ILLNESS:   Pt is a 69 y.o. female who presents today with 2 weeks of covid symptoms. She has progressively worsened in terms of cough and dyspnea. She first tested + on 11/19/21. At that time she was experiencing fatigue, nausea, poor po intake, subjective fevers (not objective), and now dyspnea that has worsened. She has a hx of esrd post renal transplant now Ckd3 on transplanted kidney off HD on prograf and cellcept. She received both her covid-19 vaccines and booster dose. She was trying to get MAB out patient but was having a hard time getting a hold of them and then it was the weekend and then she was > 10 days symptoms.    O2 was 86% in the E.D. requiring 2L with activity. She was otherwise hemodynamically stable. Cmp with bic 19 and Cr 1.5 (baseline 1.1-1.2). Cbc unremarkable except lymphopenia. CXR with patchy and confluent airspace opacities consistent with covid-19 pneumonia and calcified hylar nodes.   In the E.D. she was given azithromycin, rocephin, decadron and 1 L of iv fluids. Her spouse is at bed side and assists with history.
15Mar91 got vaxs before 12noon.Ran T of 102 @ day care approx 2pm;Tempra given to alleviate T @ 130pm.16Mar91 pt taken to ER /w vomiting,T-105.5. Rt leg @ inject site red&hot size of tennis ball& tender to touch.No sz.Suppository for vomit.
Consistent Muscle spasms in my heart and chest all day and night.  I am presently on a heart rate monitor.
HOT FLASHES; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient's past medical history included hot flashes, and concurrent conditions included menopause.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose was not reported, administered on 30-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAY-2021, the subject experienced hot flashes. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from hot flashes. This report was non-serious.
24 hour high fever above 103 degrees. With Tylenol/Motrin fever persisted at 100-102 degrees.
This spontaneous report was received from a journalist and refers to unspecified number of female patients of unknown age (reported as young). There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patients were vaccinated with GARDASIL for prophylaxis (dose, route and site of administration, lot number and expiration date were not reported). On unknown dates (reported as follow vaccinations), the patients experienced life-threatening or lethal side effects. The cause o f death was not provided. The outcome of the events was unknown. The relatedness between the events and the GARDASIL was not provided. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1905USA003023: US-009507513-1905USA003024: US-009507513-1905USA003025: US-009507513-1905USA003113.
Vaccine given on 11/7/22 and expiratory date was 11/6/22
Treatment- prescribed MEDROL DOSEPAK, 80 mg DEPO MEDROL IM- right buttocks. Adverse - swelling on right arm 4-5 cm below and above injection site.
After receiving vaccine within 24 hours started getting a body rash. Started on left arm/wrist and spread to neck chest and right arm/wrist.  She too Benadryl 50mg and remained at work. When she finished her 12 hour shift she took Tylenol. The rash  lasted for about 24 hours, by the next day it was faded, no treatment needed. Gone within 48 hours.
The patient reported that after his first covid shot that he experienced  a rash and welts on his arm.  He does not think that it was the vaccine that caused the reaction because he has idiopathic urticaria that has been ongoing.
This case was reported by a healthcare professional (physician therapist, subject) and described the occurrence of injection site soreness in a male subject of unspecified age who was vaccinated with influenza virus vaccine (manufacturer unspecified). The subject's medical history included anaphylaxis. The subject had an "anaphylactic response to anything related to penicillin (i.e. amoxicillin) in which he lost consciousness and went into atrial fibrillation for several hours." In 2002 (approximately 10 years ago), 2003 and 2004 the subject received a dose each year of influenza vaccine (unknown details). In 2002, approximately 10 years ago, less than one day after vaccination with influenza vaccine (unknown arm), the subject experienced injection site soreness. The subject described his experience as "a mild injection site reaction in which his arm was sore after receiving the flu vaccine." "The next two years, he got sick each time after receiving the flu vaccine." The injection site soreness resolved 2 days after receiving the vaccination. The subject reports that he did consult his health care provider regarding the event. In approximately 2003, the next day following a flu shot, the subject reports that he was sick, fever, weakness, tiredness and pain. The subject reports that he "felt feverish, weak, tired and achy and believes these events were systemic in nature." The subject reported that these symptoms resolved 2 to 3 days after receiving the vaccination. The subject reports that he did consult his health care provider regarding the event. In approximately 2004, the next day following a flu shot, the subject reports that was sick, fever, weakness, tiredness and pain. The subject reports that he "felt feverish, weak, tired and achy and believes these events were systemic in nature." The subject reported that these symptoms resolved 2 to 3 days after receiving the vaccination. The subject reports that he did consult his health care provider regarding the event. The subject stated that "he decided not to receive the flu vaccine anymore because each year the symptoms worsened. This year his company is requiring him to receive a flu vaccine and he is considering receiving it again." At the time to this reporting, all adverse events had resolved. Follow up was received from the healthcare provider (patient) on 20 November 2012. The reporter added that he received a dose of influenza vaccine (unknown details) on an unknown date. Approximately 5-6 years ago after vaccination with "flu-vaccine" the subject experienced flu-like symptoms. The flu-like symptoms were resolved 3 days later. The reporter stated that the flu-like symptoms were not serious. The reporter also stated that he had no adverse events following previous vaccinations.
Patient reported being sweaty, chills, extreme pain "throbbing" pain. She stated she just wanted to lay down, had limited range of motion and went to ER for treatment.
Tachycardia.  Had patient sit in chair. Monitored heart rate, oxygen level and BP. Tachycardia resolved without complication. No other symptoms noted. Total duration for event and monitoring was 60 minutes.
24 hours post-vaccination, patient reported sore, achy, swollen right arm. 6 days post-vaccination, patient reported redness below vaccination site and bruising on vaccination site. Vaccination site is 7 inches from top of shoulder.
Started with joint inflammation and pain in right knee and progressed over weeks with overall muscle tightness, stiffness and pain. Joints affected are knees, big toes and small bone at base of right thumb.  Right knee is the most severe with pain, stiffness and muscle tightness and weakness - making prolonged walking or going upstairs / getting down or up from the floor difficult.  Other odd symptoms are random pains throughout muscles/ joints the "move" from place to place  and tingling or zapping pains in bones of feet and legs. Toes turn blue/purple.  I was fine before the injections and was doing  an at home walking program.  Can no longer do this without pain and have limited endurance. To me this appears to be an autoimmune reaction.
Flushing, nausea, vomiting, headache, blurred vision. Given Benadryl 25mg and Pepcid 20mg and sent to ER.
The next mornin10/20/2020 after receiving the Fluzone vaccine she noticed his left thigh at the vaccine site was red, swollen and hot.  That night she marked a circle on his thigh where it was red, swollen and hot.  10/21/2020 the parents brought him in to the clinic to see the pediatrician and the red, swollen hot area measured 10-12 cm.  No streaks or weeping.  Dr. advised they apply cold packs to the area and give him Tylenol if he complained of pain.  At this time he was active and walking/running.  10/22/2020 10:30 AM his mother reports the area now is barely visible.
Rash on arm, itchy. Warm at night. Advised at this time to take some BENADRYL.
Immediately after the immunization, patient had loss of motion in arm and experienced pain. The patient visited the physician once in November and December. Because of the pain and lack of motion, the patient is in physical therapy two to three times a week. The patient also had an X Ray.
I contracted COVID-19. I had flu-like symptoms, head congestion, coughing, runny nose, and sneezing. I was very tired and lethargic. I was prescribed PAXLOVID on 3/12/2023. I started to feel better almost immediately after taking the medication. But It took about three weeks for all the symptoms to clear up.
Approximately 15 minutes after vaccination with dose #1, client developed rash on right arm and wheezing.  Client used her own inhaler but continued to have wheezing and complained of shortness of breath.  Client transported to the emergency room.
Vomiting, started 48 hrs after IPV. Temp 103.3, diarrhea & fussy.